Archon Biosciences, Inc.

Biotechnology company developing geometrically tunable Antibody Cage (AbC) protein therapeutics. Its platform combines antibody binding affinity and specificity with generative AI protein design and structural engineering to control molecular geometry, valency, biodistribution, and target engagement, aiming to address challenging therapeutic pathways and improve biologic drugs.